The version of the article, “ARUBA Results Are Not Applicable to All Patients With Arteriovenous Malformation” by Amin-Hanjani that published ahead-of-print on March 11, 2014, and appears in the May issue (Stroke. 2014;45:1539–1540) had several errors.
In the second paragraph, it should read, “Consequently, the former are typically considered favorable for surgical intervention, and the latter, high risk.” In the third paragraph, it should state, “Based on the grade 3 designation, this 4-cm AVM may either have deep drainage or reside in eloquent territory; dependent on those specific features, choice of treatment modality can be tailored to achieve an expected >90% favorable outcome.6” Finally, the last sentence of the article should read, “Thus, misinterpretation of ARUBA as a justification for universal denial of referral or treatment to all patients with unruptured AVMs would be, at best, irresponsible.” The publisher regrets the error.
This has been corrected in the online and print version of the article.
- © 2014 American Heart Association, Inc.